Prognostic value of MRD monitoring based on BCR-ABL1 copy numbers in Philadelphia chromosome positive acute lymphoblastic leukemia-Reference-Cited by-同舟云学术

Prognostic value of MRD monitoring based on BCR-ABL1 copy numbers in Philadelphia chromosome positive acute lymphoblastic leukemia

Published:2020-08-27 Issue:14 Volume:61 Page:3468-3475
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Arunachalam Arun Kumar¹^ORCID,Janet Nancy Beryl¹,Korula Anu¹,Lakshmi Kavitha M.¹,Kulkarni Uday P.¹,Aboobacker Fouzia N.¹^ORCID,Abraham Aby¹,George Biju¹,Balasubramanian Poonkuzhali¹,Mathews Vikram¹

Affiliation:

1. Department of Hematology, Christian Medical College, Vellore, India

Funder

DBT-COE

DBT India Alliance

New Delhi, India

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2020.1811272

Reference38 articles.

1. Long-term follow-up of a phase 2 study of chemotherapy plus dasatinib for the initial treatment of patients with Philadelphia chromosome-positive acute lymphoblastic leukemia

2. Tyrosine Kinase Activity and Transformation Potency of bcr-abl Oncogene Products

3. Long-term results of large prospective trials in childhood acute lymphoblastic leukemia

4. Prospective outcome data on 267 unselected adult patients with Philadelphia chromosome–positive acute lymphoblastic leukemia confirms superiority of allogeneic transplantation over chemotherapy in the pre-imatinib era: results from the International ALL Trial MRC UKALLXII/ECOG2993

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Outcome of Pediatric Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Experience from a Referral Center in South India;Indian Journal of Hematology and Blood Transfusion;2023-08-09

2. Clinical significance of end of induction measurable residual disease monitoring in B‐cell acute lymphoblastic leukemia: A single center experience;Cytometry Part B: Clinical Cytometry;2023-08-09

3. Novel precision medicine approaches and treatment strategies in hematological malignancies;Journal of Internal Medicine;2023-08-07

4. Minimal Residual Disease in the Management of B-Cell Acute Lymphoblastic Leukemia: A Systematic Review of Studies from Indian Settings;Indian Journal of Hematology and Blood Transfusion;2023-03-30